By NewsDesk  @infectiousdiseasenews Valley Fever, also known as coccidioidomycosis, is caused by the spore of a fungus that grows in soil in parts of California, Arizona, and other areas of the southwestern...

The California Department of Public Health (CDPH) is reporting that in 2017, 7,466 new cases of Valley Fever were reported, making 2017 the highest annual incidence reported in California since coccidioidomycosis...

The number of Coccidioidomycosis, or Valley fever cases are being reported as increased numbers during the first half of the year, according to Centers for Disease Control and Prevention (CDC) data. Through...

Valley fever cases in November saw a 50-percent spike over the previous month, leading experts at the University of Arizona Valley Fever Center for Excellence to predict a significant increase in cases...

For the first time since May, San Luis Obispo County (SLO) health officials have reported a death due to the fungal infection, Valley Fever, or coccidioidomycosis, making it the sixth of the year. According...

On Tuesday, the California Department of Public Health (CDPH) announced an increase in the number of new Valley Fever cases reported from local health departments in California through October 31, 2017,...

Health officials in Los Angeles County announced Friday  that the number of reported Valley Fever infections continues to increase. In 2016, a total of 714 cases were reported across Los Angeles County,...

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to VT-1598, a novel oral agent for the treatment of coccidioidomycosis, also known as Valley Fever, according to Viamet Pharmaceuticals...

A person has recently died in San Luis Obispo County from Valley Fever, the county’s fifth death this year from the disease. The County of San Luis Obispo Public Health Department reminds residents...

Viamet Pharmaceuticals announced on Thursday that the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) designation to VT-1598, a novel candidate for the oral...